Cargando…
Long-term follow-up in an open-label trial of triheptanoin in GLUT1 deficiency syndrome: a sustained dramatic effect
Autores principales: | Hainque, Elodie, Gras, Domitille, Meneret, Aurélie, Atencio, Mariana, Luton, Marie-Pierre, Barbier, Magali, Doulazmi, Mohamed, Habarou, Florence, Ottolenghi, Chris, Roze, Emmanuel, Mochel, Fanny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6860903/ https://www.ncbi.nlm.nih.gov/pubmed/30948626 http://dx.doi.org/10.1136/jnnp-2018-320283 |
Ejemplares similares
-
Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency
por: Mochel, Fanny, et al.
Publicado: (2016) -
A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood
por: Hainque, Elodie, et al.
Publicado: (2017) -
CD8 T cell deficiency impairs control of Epstein–Barr virus and worsens with age in multiple sclerosis
por: Pender, Michael P, et al.
Publicado: (2011) -
Correction
Publicado: (2011) -
Correction
Publicado: (2011)